Danny Benjamin
Impact in
- Clinical Biochemistry top 5%
- Bacterial Identification and Susceptibility Testing
Papers in
-
- Antimicrobial Resistance in Staphylococcus 2
- Antifungal resistance and susceptibility 1
-
- Neonatal and Maternal Infections 3
- Health and Medical Research Impacts 1
- Co-authors
- Vivian H. Chu (1 shared paper)Lynda A. Szczech (1 shared paper)Zeina A. Kanafani (1 shared paper)John J. Engemann (1 shared paper)L. Barth Reller (1 shared paper)Jula K. Inrig (1 shared paper)G. Ralph Corey (1 shared paper)Martín E. Stryjewski (1 shared paper)
- Journals
- PEDIATRICS (2 papers)Drug Resistance Updates (1 paper)Clinical Infectious Diseases (1 paper)Advances in experimental medicine and biology (1 paper)AIDS Patient Care and STDs (1 paper)
- Partner nations
- United StatesUnited KingdomArgentina
In The Last Decade
Danny Benjamin
11 papers receiving 664 citations
Peers
Comparison fields: 5 of 62
- Clinical Biochemistry 128
- Applied Microbiology and Biotechnology 24
- Infectious Diseases 218
- Physiology 257
- Rheumatology 99
Countries citing papers authored by Danny Benjamin
This map shows the geographic impact of Danny Benjamin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danny Benjamin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danny Benjamin more than expected).
Fields of papers citing papers by Danny Benjamin
This network shows the impact of papers produced by Danny Benjamin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danny Benjamin. The network helps show where Danny Benjamin may publish in the future.
Co-authors
The 25 scholars most cited alongside Danny Benjamin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 302 | |
| 2 | 2006 | 282 | |
| 3 | 2005 | 38 | |
| 4 | 2012 | 27 | |
| 5 | 2019 | 18 | |
| 6 | 2020 | 9 | |
| 7 | 2019 | 9 | |
| 8 | 2004 | 7 | |
| 9 | 2009 | 3 | |
| 10 | 2018 | 3 | |
| 11 | 2018 | 2 |
About Danny Benjamin
Danny Benjamin is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health, Pharmacology and Virology, having authored 11 papers that have together received 700 indexed citations. Recurring topics across this work include Neonatal and Maternal Infections (3 papers), Childhood Cancer Survivors' Quality of Life (2 papers), Antimicrobial Resistance in Staphylococcus (2 papers), Adolescent and Pediatric Healthcare (1 paper), Antifungal resistance and susceptibility (1 paper), Health and Medical Research Impacts (1 paper), Fungal Infections and Studies (1 paper) and Cystic Fibrosis Research Advances (1 paper). The work is most often cited by research in Clinical Biochemistry (128 citations), Applied Microbiology and Biotechnology (24 citations), Infectious Diseases (218 citations), Physiology (257 citations) and Rheumatology (99 citations). Danny Benjamin has collaborated with scholars based in United States, United Kingdom and Argentina. Frequent co-authors include Vivian H. Chu, Lynda A. Szczech, Zeina A. Kanafani, John J. Engemann, L. Barth Reller, Jula K. Inrig, G. Ralph Corey, Martín E. Stryjewski, Vance G. Fowler and Maria Joyce. Their work appears in journals such as PEDIATRICS, Drug Resistance Updates, Clinical Infectious Diseases, Advances in experimental medicine and biology and AIDS Patient Care and STDs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.